Biotech

All Articles

Amgen files very first stage 3 gain for $400M chronic eczema drug

.Amgen has actually discussed (PDF) the first stage 3 data on its own $400 thousand dermatitis medic...

Biogen, UCB record phase 3 lupus gain after falling short earlier trial

.Biogen and UCB's gamble on advancing right into stage 3 astride a broken research study hopes to ha...

Aptadir really hopes brand-new RNA inhibitors can easily reverse difficult cancers cells

.Italian biotech Aptadir Therapies has actually introduced along with the pledge that its own pipe o...

Wave surfs DMD effectiveness to regulators' doors, delivering stock up

.Surge Lifestyle Sciences has fulfilled its target in a Duchenne muscle dystrophy (DMD) research stu...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupyi...

Achilles drops tissue treatment program, prepares for layoffs after overlooking 'business viability' objectives

.Achilles Rehabs has actually torn up its own method. The British biotech is actually knocking off o...

Aligos proclaims period 2 MASH win, reducing liver body fat approximately 46%

.Aligos Rehabs is actually advertising a midstage succeed in metabolic-dysfunction associated steato...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job building new antifungals has gotten a significant boost from the united...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Having presently gathered up the USA civil rights to Capricor Therapeutics' late-stage Duchenne mus...

FDA fragments adcomm for Applied's rare condition drug

.After pushing back the choice date for Applied Rehabs' metabolic ailment drug govorestat, the FDA h...